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Inclusion criteria 
Studies:  
Randomized controlled trials. 
Participants: 
Adults and children with acute diarrhoea confirmed 
(by stool microscopy or stool culture) or presumed to 
be caused by Vibrio cholerae. 
Intervention: 
Intervention: reduced osmolarity ORS (total osmolarity 
250 mmol/L with reduced sodium). 
Control: standard ORS (total osmolarity 311 mmol/L 
with 90 mmol/L sodium and 111 mmol/L glucose). 
Outcomes: 
Primary: need for unscheduled intravenous infusion; 
symptomatic hyponatraemia, as defined by trialists. 
Secondary: biochemical hyponatraemia, as defined by 
trialists; duration of diarrhoea; stool volume in first 24 
hours after admission or randomization; vomiting 
during rehydration; death. 
Results 
Seven trials assessed glucose-based reduced osmolarity 
ORS; two were adequately concealed.  
• Five trials (n=616) reported on need for 
unscheduled intravenous infusion and showed no 
difference between glucose-based reduced 
osmolarity and standard ORS (relative risk 0.86, 
95% confidence interval 0.66 to 1.12). 
• No trials reported symptomatic hyponatraemia. 
Four trials (n=465) showed biochemical 
hyponatraemia was more common with glucose-
based reduced osmolarity ORS (RR 1.67, 95% CI 
1.09 to 2.57), but showed no difference in severe 
biochemical hyponatraemia between the groups  
(RR 1.58, 95% CI 0.62 to 4.04). 
Two trials (102 participants) also assessed rice-based 
reduced osmolarity ORS; neither were adequately 
concealed. The duration of diarrhoea was shorter in 
the reduced osmolarity ORS group (weighted mean 
difference 16.85 hours, 95% CI 12.48 to 21.22). 
Is reduced osmolarity oral rehydration solution (ORS) better than  
standard solution for treating diarrhoea due to cholera? 
In people with cholera, markers of diarrhoea severity with reduced osmolarity ORS 
were similar to standard solution, apart from asymptomatic hyponatraemia, 
which was more common. 
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Authors’ conclusions 
Implications for practice:  
Reduced osmolarity ORS increases the risk of biochemical hyponatraemia but the limited evidence to date has 
not demonstrated a difference in the need for unscheduled intravenous infusion or other markers of diarrhoea 
severity in people with cholera. 
Implications for research: 
Further randomized controlled trials are needed to assess the balance between benefit and harm associated with 
the use of reduced osmolarity ORS in people with cholera. These trials should be large enough to adequately 
assess important outcomes, such as symptomatic hyponatremia and death. 
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